TITLE

ALTANA PHARMA BUSINESS SOLD

PUB. DATE
September 2006
SOURCE
ICIS Chemical Business;9/25/2006, Vol. 1 Issue 36, p4
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
This article reports on the sale of Altana's pharmaceuticals business to Nycomed in Denmark. The business was sold for €4.5 billion. The deal will break up one of Europe's few remaining combined pharmaceutical and chemicals groups, is expected to close by the end of this year, subjected to regulatory approvals.
ACCESSION #
22669967

 

Related Articles

  • Altana sale feasible.  // Chemical Market Reporter;10/24/2005, Vol. 268 Issue 14, p5 

    Reports on the significance of the sale of Altana AG's pharmaceuticals division in the U.S. Consideration of the sale as logical; Value of the pharmaceuticals division; Projection on the value of the possible sale.

  • Altana may sell pharma division. Robinson, Simon // European Chemical News;10/24/2005, Vol. 83 Issue 2168, p7 

    This article reports that German pharmaceuticals and chemicals manufacturer Altana may be planning to sell its $2 billion pharmaceuticals division. The Bad Homburg firm, owned 50.1% by heiress Susanne Klatten, is said to have approached several larger drugs players about a deal. Roche, which had...

  • Altana considers divesting pharma business.  // PharmaWatch: Monthly Review;Dec2005, Vol. 4 Issue 12, p28 

    The article reports that Altana AG is considering the sale its pharmaceuticals arm, following a disappointing year for the company's pharmaceutical unit. This move of the company has significantly boosted trading volumes of the company's stock, and increased interest in the company. Altana would...

  • Pharma and Suppliers Consolidate. Greb, Erik; Harrison, Brianne; Rios, Maribel; Van Arnum, Patricia // Pharmaceutical Technology;Nov2006, Vol. 30 Issue 11, p24 

    The article offers news briefs related to pharmaceutical company consolidations. Altana AG plans to sell Altana Pharma AG and its entire pharmaceuticals business to Nycomed for 4.5 million Euro. AnorMed Inc. determined that Genzyme's $580 million offer to acquire all outstanding AnorMED shares...

  • Altana buys Valspar's overprint varnishes business.  // European Coatings Journal;2013, Issue 12, p8 

    The article reports on the purchase of The Valspar (France) Corp.'s European water-based and ultraviolet (UV) overprint varnishes business by specialty chemicals group Altana.

  • What's really going on at Nycomed? Goldblatt, Dan // Business News New Jersey;10/02/96, Vol. 9 Issue 20, p4 

    Looks at the stock performance of West Windsor, New Jersey-based drug company Nycomed Inc. from May to September 1996. Decrease in the earnings per share; Estimated Nycomed's margins over its competitors; Stock analysts' apprehensions about the potential performance of Nycomed.

  • Altana acquires polypropylene wax emulsions business of DSM.  // European Coatings Journal;2014, Issue 3, p8 

    The article reports that Altana, a chemicals group company, has acquired the polypropylene wax emulsions business from Royal DSM, a multinational life sciences company.

  • New Altana unit opening in Melville, moving to NJ. Solnik, Claude // Long Island Business News (7/1993 to 5/2009);9/28/2001, Vol. 48 Issue 40, p8A 

    Reports on the expansion of pharmaceutical firm Altana AG in Melville, New York. Maximization of corporate profits; Distribution of pharmaceutical products; Increase on the number of branches.

  • Akzo Nobel takes top spot.  // European Chemical News;7/19/2004, Vol. 81 Issue 2109, p8 

    Focuses on the reason of Akzo Nobel for acquiring the French coil coatings business of German specialty chemicals and pharmaceuticals business Altana. Background of the coil coatings business of Altana; Details of the deal; Plans of Akzo Nobel.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics